Is alprazolam (Xanax) safe for treating anxiety in a patient with postural orthostatic tachycardia syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Alprazolam (Xanax) Should Generally Be Avoided in POTS Patients

Alprazolam is not recommended for treating anxiety in patients with POTS and is notably absent from evidence-based treatment guidelines for this condition. While anxiety symptoms are common in POTS patients, benzodiazepines like alprazolam can worsen orthostatic symptoms and do not address the underlying pathophysiology.

Why Alprazolam Is Problematic in POTS

Cardiovascular Effects

  • Alprazolam can cause sedation, dizziness, and hypotension 1, which directly exacerbate the core symptoms of POTS (orthostatic intolerance, lightheadedness, and cerebral hypoperfusion)
  • The drug's sedative properties may worsen the already-compromised cerebral blood flow that characterizes POTS
  • Risk of physical dependence and withdrawal reactions 1, which could complicate the already complex symptom profile in POTS patients

Not Evidence-Based for POTS

The 2020 Canadian Cardiovascular Society guidelines 2 comprehensively outline pharmacological management for POTS and do not include benzodiazepines. Recommended medications specifically target POTS pathophysiology:

  • Propranolol (10-20 mg four times daily) - reduces standing heart rate and improves symptoms
  • Midodrine - improves symptom control through vasoconstriction
  • Pyridostigmine, fludrocortisone, ivabradine, and clonidine as alternatives

The Anxiety-POTS Connection

Anxiety symptoms in POTS are often misattributed as primary psychiatric disorders when they are actually secondary to autonomic dysfunction 3. Research demonstrates that POTS patients score higher on anxiety questionnaires that include autonomic items (palpitations, dizziness, trembling), but show no difference from controls when questionnaires exclude autonomic symptoms 3. This means the "anxiety" is often the physiological experience of orthostatic stress, not a primary anxiety disorder.

Recommended Approach Instead

First-Line: Non-Pharmacological Management 2

  • Increase fluid intake to at least 3 liters daily
  • Increase salt intake to 10 grams daily (via high-salt foods or salt tablets)
  • Exercise training in semi-recumbent position (rowing, recumbent cycling, swimming) - at least 4 days/week for 30+ minutes
  • Compression garments (waist-high, 20-30 mm Hg)
  • Sleep with head elevated >10 degrees

Pharmacological Options for Symptom Control 2

If anxiety-like symptoms persist after non-pharmacological interventions:

  • Propranolol (strong recommendation, moderate-quality evidence) - addresses both tachycardia and hyperadrenergic symptoms that may manifest as "anxiety"
  • Midodrine for patients with hypotensive tendencies
  • Consider ivabradine or pyridostigmine as second-line options

When True Anxiety Disorder Coexists

If genuine anxiety disorder is confirmed (not just autonomic symptoms):

  • SSRIs are safer alternatives - the FDA label notes sertraline did not significantly interact with alprazolam pharmacokinetics 1, suggesting SSRIs may be better tolerated
  • Cognitive behavioral therapy targeting both POTS symptom management and anxiety
  • Address the POTS first - many "anxiety" symptoms resolve with proper POTS treatment 4

Critical Pitfalls to Avoid

  1. Misdiagnosing POTS symptoms as primary anxiety disorder - this leads to inappropriate psychiatric treatment and delays proper autonomic care 5
  2. Using sedating medications that worsen orthostatic tolerance
  3. Ignoring the evidence-based POTS treatments that actually improve quality of life 4
  4. Prescribing alprazolam long-term - FDA labeling notes safety/efficacy for anxiety is only established for <4 months 1

Bottom Line

Treat the POTS first with guideline-directed therapies 2. The majority of patients experience meaningful functional improvement with propranolol, increased salt/fluid intake, and exercise training 4. If anxiety symptoms persist despite optimized POTS management, consider non-benzodiazepine anxiolytics rather than alprazolam, which carries risks of worsening orthostatic symptoms, dependence, and does not address the underlying autonomic dysfunction.

References

3
Research

[Anxiety in patients with postural tachycardia syndrome (POTS)].

Fortschritte der Neurologie-Psychiatrie, 2012

Related Questions

In a patient with postural orthostatic tachycardia syndrome (POTS), chronic migraine, chronic fatigue, gastroesophageal reflux disease (GERD), attention-deficit/hyperactivity disorder (ADHD), and post‑traumatic stress disorder (PTSD) who has difficulty gaining weight, altered bowel habits, and recurrent GERD, what labs, procedures, and differential diagnoses should be considered?
What is the recommended propranolol dosing, titration, and monitoring for a patient with postural orthostatic tachycardia syndrome (POTS) who has symptomatic tachycardia on standing and no contraindications?
How should beta‑blockers be used to treat postural orthostatic tachycardia syndrome (POTS)?
In a 14-year-old male with postural orthostatic tachycardia syndrome presenting with exertional tachycardia and vomiting, what cardiac and other evaluations and management steps should be considered?
In a 26-year-old female with a history of fibromyalgia and postural orthostatic tachycardia syndrome (POTS) presenting with new-onset spinal pain, what is the appropriate workup?
What conditions and diseases are associated with myeloperoxidase deficiency, and which genes are involved?
What does an isoechoic liver lesion with a hypoechoic halo on ultrasound signify?
In a 71-year-old man with atrial fibrillation on warfarin, who had his digoxin dose increased to 0.250 mg and was taking diltiazem 180 mg daily but stopped diltiazem four days ago, can he still experience symptoms of digoxin toxicity?
Can crying that begins after I start buspirone (Buspar) be a side effect, and how should I manage it?
Can Truvia (containing erythritol and stevia) cause diarrhea?
In a 60‑year‑old woman with chronic pelvic instability since childbirth, does a flamingo view showing a 3.3 mm vertical asymmetry of the superior pubic rami indicate pubic symphyseal insufficiency fracture or instability?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.